The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China

Cryopyrin-associated periodic syndrome (CAPS) comprises a group of disorders characterized by recurrent bouts of systemic inflammation related to overactivation of inflammasome. So far, neither large cases of the correlation between genotype and phenotype nor treatment strategies have been clearly s...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Zhou Shu, Yue Zhang, Tongxin Han, Yan Li, Yurong Piao, Fei Sun, Jin Ma, Wenxiu Mo, Jiapeng Sun, Koon-Wing Chan, Wanling Yang, Yu-Lung Lau, Huawei Mao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Subjects:	cryopyrin-associated periodic syndrome genotype and phenotype correlation novel mutation Canakinumab somatic mosaicism mutation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267933/full

Similar Items

EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
by: T. V. Sleptsova, et al.
Published: (2014-05-01)

The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
by: Svetlana Olegovna Salugina, et al.
Published: (2014-12-01)

Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China
by: Xiaona Zhu, et al.
Published: (2024-09-01)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME
by: A. L. Kozlova, et al.
Published: (2015-04-01)

Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrin-associated periodic syndromes (CAPS)
by: S. O. Salugina, et al.
Published: (2016-06-01)

CRYOPYRIN ASSOCIATED PERIODIC SYNDROME
by: M. Gattorno
Published: (2013-02-01)

A familial case of Muckle-Wells syndrome in a Russian population: The first successes of therapy with the interleukin 1 inhibitor canakinumab
by: S. O. Salugina, et al.
Published: (2015-03-01)

Progressive osseous heteroplasia in a 5-year-old boy with a novel mutation in exon 2 of GNAS: a case presentation and literature review
by: Jing Ma, et al.
Published: (2023-03-01)

Cryopyrin-associated periodic syndrome Muckle — Wells: A Case Report
by: N. V. Shakhova, et al.
Published: (2023-07-01)

Therapy with canakinumab for gout
by: M. S. Eliseev, et al.
Published: (2019-04-01)

Cryopyrin-Associated Periodic Syndrome (CAPS) Caused by c.943A>G Variant of NLRP3 Gene: Clinical Case
by: Ivan A. Kriulin, et al.
Published: (2019-11-01)

NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
by: Chiara Moltrasio, et al.
Published: (2022-10-01)

Novel mutations in Serbian MEN1 patients: Genotype-phenotype correlation
by: Isailović Tatjana, et al.
Published: (2019-01-01)

Adult onset cryopyrin-associated periodic syndrome due to germline missense mutation in NLRP3 in a previously healthy middle-aged woman
by: Sung Ik Cho, et al.
Published: (2025-08-01)

Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab
by: T. V. Sleptsova, et al.
Published: (2016-11-01)

Modulation of Inflammation in Heart Failure: The Role of Ziltivekimab and Canakinumab
by: Łukasz Wołowiec, et al.
Published: (2024-10-01)

CASE OF USING THE INHIBITOR OF INTERLEUKIN 1 CANACINUMAB IN PATIENTS WITH AUTO INFLAMMATORY DISEASES
by: S. O. Salugina, et al.
Published: (2015-04-01)

CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN
by: Ye. I. Alekseeva, et al.
Published: (2014-12-01)

<i>ACTB</i> Mutations Analysis and Genotype–Phenotype Correlation in Becker’s Nevus
by: Shangzhi Dai, et al.
Published: (2021-12-01)

Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab
by: Angel Luis Salcedo-Mingoarranz, et al.
Published: (2023-12-01)

Therapy with canakinumab for adult-onset still's disease
by: E. L. Nasonov
Published: (2019-04-01)

Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes
by: Irene Lobon, et al.
Published: (2022-04-01)

EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME
by: Tatyana V. Sleptsova, et al.
Published: (2016-11-01)

Description and phenotype of a novel C5 gene mutation and a novel combination: family report and literature review
by: Asier Lizama-Muñoz, et al.
Published: (2025-07-01)

The Role of Interleukin-1 Beta C-511T as a Modifier Polymorphism in Cryopyrin-associated Periodic Syndromes
by: Berk Özyılmaz, et al.
Published: (2019-09-01)

From Urticaria to Correct Diagnosis: A Case Report of Cryopyrin-Associated Periodic Syndromes
by: Wang X, et al.
Published: (2025-04-01)

EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
by: Maksim Sergeyevna Eliseev, et al.
Published: (2014-03-01)

Case report: VEXAS as an example of autoinflammatory syndrome in pulmonology clinical practice
by: Ewa Więsik-Szewczyk, et al.
Published: (2024-01-01)

CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-09-01)

Use of anakinra in cryopyrin-associated periodic syndromes: case report and review of literature
by: Marta Salas Sánchez, et al.
Published: (2025-06-01)

Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
by: Weidong Zhang, et al.
Published: (2025-01-01)

Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
by: Lingzhi Qiu, et al.
Published: (2024-03-01)

CINCA/NOMID is a rare autoinflammatory syndrome in rheumatological practice. Experience of diagnosis, management and therapy with interleukin-1 inhibitors
by: S. O. Salugina, et al.
Published: (2024-04-01)

Canakinumab for the management of pyoderma gangrenosum: a case series of two patients and literature review
by: Howard Jie Yang, et al.
Published: (2025-12-01)

CLINICAL CASE: USE OF CANAKINUMAB IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RESISTANT TO IMMUNOSUPPRESSANTS AND GENETICALLY ENGINEERED BIOPHARMACEUTICALS
by: E. I. Alexeeva, et al.
Published: (2014-03-01)

Is Canakinumab Safe During Pregnancy? New Insights from Three Cases in Slovakia
by: Branislav Slenker, et al.
Published: (2025-04-01)

Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases
by: Mustafa Çakan, et al.
Published: (2020-04-01)

Phenotypic and genotypic characteristics of children with Bartter syndrome
by: Serçin Güven, et al.
Published: (2022-10-01)

Relationship between genotype and phenotype of high mutation in 20 patients with gitelman syndrome
by: SHAO Chang-juan, et al.
Published: (2019-01-01)

Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
by: Mikhail M. Kostik
Published: (2016-12-01)